JPS57126420A - Drug for digestive organ - Google Patents
Drug for digestive organInfo
- Publication number
- JPS57126420A JPS57126420A JP1065481A JP1065481A JPS57126420A JP S57126420 A JPS57126420 A JP S57126420A JP 1065481 A JP1065481 A JP 1065481A JP 1065481 A JP1065481 A JP 1065481A JP S57126420 A JPS57126420 A JP S57126420A
- Authority
- JP
- Japan
- Prior art keywords
- carnitine
- drug
- acyl
- effective
- active constituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
PURPOSE: A drug for digestive organs, containing carnitine or a derivative thereof as an active constituent, and effective for preventing and treating anorexia, weight increase disorder, etc.
CONSTITUTION: A drug for digestive organs, containing at least one selected from d-carnitine, l-carnitine, acyl-d-carnitine, acyl-dl-carnitine, acyl-l-carnitine and a physiologically acceptable salt thereof as an active constituent. The carnitine is distributed in organisms widely ranging from men to microorganisms, and contained in a muscle or pancreatic juice in a large amount. The drug is administered most preferably orally, and the daily dose thereof is 5W100mg per adult divided in about 3 fractions. The drug is effective for promoting the appetite and increasing the body weight with low toxicity and no side effects.
COPYRIGHT: (C)1982,JPO&Japio
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1065481A JPS57126420A (en) | 1981-01-26 | 1981-01-26 | Drug for digestive organ |
JP41814490A JPH03246221A (en) | 1981-01-26 | 1990-12-21 | Rearing promoter |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1065481A JPS57126420A (en) | 1981-01-26 | 1981-01-26 | Drug for digestive organ |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP41814490A Division JPH03246221A (en) | 1981-01-26 | 1990-12-21 | Rearing promoter |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57126420A true JPS57126420A (en) | 1982-08-06 |
JPH0340010B2 JPH0340010B2 (en) | 1991-06-17 |
Family
ID=11756204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1065481A Granted JPS57126420A (en) | 1981-01-26 | 1981-01-26 | Drug for digestive organ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57126420A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839159A (en) * | 1988-02-08 | 1989-06-13 | Topicarn, Inc. | Topical L-carnitine composition |
US4883672A (en) * | 1988-04-29 | 1989-11-28 | Shug Austin L | Method for preventing diet induced carnitine deficiency in domesticated dogs and cats |
GB2230953A (en) * | 1989-05-05 | 1990-11-07 | Sigma Tau Ind Farmaceuti | Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease |
WO1991005554A1 (en) * | 1989-10-23 | 1991-05-02 | University Of Georgia Research Foundation, Inc. | Carnitine supplemented cat fish diet |
US5071874A (en) * | 1989-06-14 | 1991-12-10 | Lonza Ltd. | L-carnitine magnesium citrate |
US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
US5240961A (en) * | 1992-07-02 | 1993-08-31 | Shug Austin L | Method of treating reduced insulin-like growth factor and bone loss associated with aging |
US5314689A (en) * | 1988-05-26 | 1994-05-24 | Attilio Bernardini | Acyl-carnitine for the treatment and prevention of viral infections |
US5362753A (en) * | 1993-04-19 | 1994-11-08 | Lonza Ltd. | Method of increasing the hatchability of eggs by feeding hens carnitine |
US6242487B1 (en) | 1996-12-03 | 2001-06-05 | Lonza, Inc. | Carnitine supplemented diets for gestating and lactating swine |
-
1981
- 1981-01-26 JP JP1065481A patent/JPS57126420A/en active Granted
Non-Patent Citations (1)
Title |
---|
CHEM.ABSTR * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839159A (en) * | 1988-02-08 | 1989-06-13 | Topicarn, Inc. | Topical L-carnitine composition |
US4883672A (en) * | 1988-04-29 | 1989-11-28 | Shug Austin L | Method for preventing diet induced carnitine deficiency in domesticated dogs and cats |
US5314689A (en) * | 1988-05-26 | 1994-05-24 | Attilio Bernardini | Acyl-carnitine for the treatment and prevention of viral infections |
GB2230953A (en) * | 1989-05-05 | 1990-11-07 | Sigma Tau Ind Farmaceuti | Compositions containing D-carnitine or an acyl derivative for the treatment of protozoal disease |
GB2230953B (en) * | 1989-05-05 | 1993-03-24 | Sigma Tau Ind Farmaceuti | Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease |
US5071874A (en) * | 1989-06-14 | 1991-12-10 | Lonza Ltd. | L-carnitine magnesium citrate |
WO1991005554A1 (en) * | 1989-10-23 | 1991-05-02 | University Of Georgia Research Foundation, Inc. | Carnitine supplemented cat fish diet |
US5030657A (en) * | 1989-10-23 | 1991-07-09 | University Of Georgia Research Foundation, Inc. | L-carnitine supplemented catfish diet |
US5073376A (en) * | 1989-12-22 | 1991-12-17 | Lonza Ltd. | Preparations containing l-carnitine |
WO1994001101A1 (en) * | 1992-07-02 | 1994-01-20 | Shug Austin L | A method of treating reduced insulin-like growth factor and bone loss associated with aging |
US5240961A (en) * | 1992-07-02 | 1993-08-31 | Shug Austin L | Method of treating reduced insulin-like growth factor and bone loss associated with aging |
US5362753A (en) * | 1993-04-19 | 1994-11-08 | Lonza Ltd. | Method of increasing the hatchability of eggs by feeding hens carnitine |
US6242487B1 (en) | 1996-12-03 | 2001-06-05 | Lonza, Inc. | Carnitine supplemented diets for gestating and lactating swine |
Also Published As
Publication number | Publication date |
---|---|
JPH0340010B2 (en) | 1991-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR920000324A (en) | Essential Fatty Acid Treatment | |
ES2077530A1 (en) | Pharmaceutical products for curing tumorous diseases and process for preparing same | |
TNSN99163A1 (en) | ANTIOXIDANT COMPOSITION COMPRISING ACETYL-CARNITINE AND α -LIPOIC ACID WHICH IMPROVES THE METABOLIC USE OF GLUCOSE | |
UA41446C2 (en) | Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition | |
RO116342B1 (en) | Oral liquid pharmaceutical composition | |
GB9517443D0 (en) | Increasing creatine and glycogen concentration in muscle | |
KR940018089A (en) | Prevention and treatment for radiation damage of internal tissue | |
CS545686A1 (en) | Farmaceuticky prostredek a antihepatotoxickym pusobenim | |
JPS57126420A (en) | Drug for digestive organ | |
KR930000114A (en) | Treatment with fatty acids | |
DE3751036T2 (en) | Pharmaceutical substances directed by carnitine and their use in the manufacture of a medicament for the treatment of muscle disorders. | |
JPS56104815A (en) | Remedy for peripheral orthostatic hypotension | |
GR3015431T3 (en) | Use of acetyl L-carnitine in the therapeutic treatment of coma. | |
CA2386770A1 (en) | Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba | |
ATE184788T1 (en) | COMPOSITIONS CONTAINING IDEBENONE FOR THE TREATMENT OF ALZHEIMER'S M | |
HK1009325A1 (en) | Composition comprising l-carnitine or acyl-l-carnitine in combination with an ace-inhibitor for the treatment of cardiovascular disorders | |
CA2108330A1 (en) | Enhancer for the Antianemia Effect of Erythropoietin and Method of Augmenting the Antianemia Effect of Erythropoietin | |
KR920702225A (en) | Pharmaceutical composition | |
NZ303993A (en) | Pharmaceutical compositions containing aminotetralin derivatives for treating cardiac disorders | |
JPS57112331A (en) | Medical composition of ganoderma lucidum component | |
GB2258397A (en) | Pharmaceutical compositions containing amethocaine | |
DE68910010D1 (en) | Use of dapiprazole in the manufacture of a medicament for preventing tolerance development in analgesic treatment with morphine. | |
IL101908A (en) | Process for extraction of antineoplastic substances from plants of the family pittosporaceae, extracts obtained thereby, and pharmaceutical preparations containing them | |
CA2103707A1 (en) | Treatment of non-small cell lung carcinoma | |
Kiesel et al. | Prevention of diabetes in BB rats by an E. coli extract(OM-89) |